Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholecystectomy, Laparoscopic | 17 | 2022 | 31 | 3.910 |
Why?
|
| Cholecystitis, Acute | 7 | 2022 | 7 | 2.150 |
Why?
|
| Cholecystectomy | 8 | 2021 | 16 | 1.920 |
Why?
|
| Laparoscopy | 13 | 2022 | 159 | 1.770 |
Why?
|
| Bile Ducts | 8 | 2021 | 10 | 1.390 |
Why?
|
| Gallstones | 3 | 2022 | 8 | 1.330 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2022 | 1 | 0.810 |
Why?
|
| Practice Guidelines as Topic | 6 | 2018 | 288 | 0.760 |
Why?
|
| Postoperative Complications | 16 | 2018 | 862 | 0.720 |
Why?
|
| Bile Duct Diseases | 4 | 2021 | 5 | 0.660 |
Why?
|
| Cholangitis | 5 | 2018 | 5 | 0.620 |
Why?
|
| Pancreatic Neoplasms | 8 | 2013 | 64 | 0.600 |
Why?
|
| Humans | 63 | 2022 | 25965 | 0.560 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 929 | 0.540 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 3 | 2018 | 8 | 0.520 |
Why?
|
| Endosonography | 3 | 2017 | 9 | 0.520 |
Why?
|
| Gallbladder Diseases | 1 | 2015 | 4 | 0.510 |
Why?
|
| Intraoperative Complications | 4 | 2020 | 63 | 0.510 |
Why?
|
| Mesothelioma, Cystic | 1 | 2014 | 2 | 0.480 |
Why?
|
| Peritoneal Neoplasms | 1 | 2014 | 7 | 0.480 |
Why?
|
| Cysts | 3 | 2008 | 15 | 0.460 |
Why?
|
| Cholecystitis | 1 | 2013 | 10 | 0.440 |
Why?
|
| Kidney Diseases | 1 | 2014 | 99 | 0.440 |
Why?
|
| Kidney | 1 | 2014 | 155 | 0.430 |
Why?
|
| Quality Improvement | 4 | 2014 | 149 | 0.420 |
Why?
|
| Female | 40 | 2018 | 14348 | 0.410 |
Why?
|
| Male | 37 | 2018 | 13981 | 0.410 |
Why?
|
| Adult | 22 | 2018 | 7349 | 0.380 |
Why?
|
| Colectomy | 3 | 2016 | 17 | 0.350 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2018 | 713 | 0.350 |
Why?
|
| Middle Aged | 28 | 2018 | 8508 | 0.330 |
Why?
|
| Iatrogenic Disease | 2 | 2020 | 25 | 0.320 |
Why?
|
| Pancreatic Cyst | 2 | 2008 | 3 | 0.320 |
Why?
|
| Treatment Outcome | 13 | 2018 | 3292 | 0.320 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2008 | 21 | 0.310 |
Why?
|
| Adenocarcinoma | 6 | 2005 | 123 | 0.310 |
Why?
|
| Multimodal Imaging | 2 | 2018 | 23 | 0.300 |
Why?
|
| Video Recording | 2 | 2018 | 33 | 0.290 |
Why?
|
| Ultrasonography | 3 | 2022 | 222 | 0.280 |
Why?
|
| Length of Stay | 4 | 2018 | 301 | 0.280 |
Why?
|
| Endoscopy | 2 | 2021 | 176 | 0.280 |
Why?
|
| Liver | 3 | 2017 | 123 | 0.270 |
Why?
|
| Pancreatectomy | 3 | 2003 | 8 | 0.270 |
Why?
|
| Image-Guided Biopsy | 2 | 2018 | 32 | 0.270 |
Why?
|
| Retrospective Studies | 13 | 2018 | 3288 | 0.270 |
Why?
|
| Aged | 23 | 2018 | 8704 | 0.270 |
Why?
|
| Fellowships and Scholarships | 1 | 2006 | 37 | 0.260 |
Why?
|
| Internship and Residency | 4 | 2014 | 206 | 0.250 |
Why?
|
| Surgeons | 3 | 2021 | 76 | 0.250 |
Why?
|
| Colonic Neoplasms | 2 | 2016 | 50 | 0.230 |
Why?
|
| Drainage | 4 | 2017 | 46 | 0.230 |
Why?
|
| Biopsy | 2 | 2014 | 199 | 0.230 |
Why?
|
| Tokyo | 6 | 2018 | 6 | 0.230 |
Why?
|
| Ganglioneuroma | 2 | 2003 | 5 | 0.210 |
Why?
|
| Surveys and Questionnaires | 4 | 2021 | 1066 | 0.200 |
Why?
|
| United States | 8 | 2021 | 1971 | 0.200 |
Why?
|
| Neuroblastoma | 1 | 2002 | 17 | 0.200 |
Why?
|
| Neoplasms, Second Primary | 1 | 2002 | 33 | 0.190 |
Why?
|
| Aged, 80 and over | 8 | 2018 | 4661 | 0.190 |
Why?
|
| Stomach Neoplasms | 4 | 2015 | 24 | 0.190 |
Why?
|
| Societies, Medical | 1 | 2021 | 146 | 0.180 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1991 | 45 | 0.180 |
Why?
|
| Prospective Studies | 7 | 2018 | 1646 | 0.180 |
Why?
|
| Blood Loss, Surgical | 2 | 2018 | 55 | 0.180 |
Why?
|
| Operative Time | 2 | 2018 | 83 | 0.170 |
Why?
|
| Education, Medical, Graduate | 2 | 2014 | 74 | 0.170 |
Why?
|
| Disease Management | 2 | 2017 | 108 | 0.170 |
Why?
|
| Pancreaticoduodenectomy | 3 | 2013 | 11 | 0.170 |
Why?
|
| Hernia, Ventral | 2 | 2014 | 19 | 0.170 |
Why?
|
| Surgical Mesh | 2 | 2014 | 22 | 0.170 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 342 | 0.170 |
Why?
|
| Stents | 2 | 2017 | 73 | 0.170 |
Why?
|
| Safety | 2 | 2016 | 39 | 0.170 |
Why?
|
| Hernia, Inguinal | 2 | 1996 | 17 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 338 | 0.150 |
Why?
|
| Carcinoma | 2 | 2016 | 59 | 0.150 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 335 | 0.150 |
Why?
|
| Patient Admission | 1 | 2018 | 25 | 0.150 |
Why?
|
| Cholelithiasis | 3 | 1995 | 9 | 0.150 |
Why?
|
| Lymph Nodes | 1 | 2018 | 62 | 0.150 |
Why?
|
| Survival Rate | 6 | 2018 | 321 | 0.150 |
Why?
|
| General Surgery | 2 | 2014 | 47 | 0.150 |
Why?
|
| Herniorrhaphy | 2 | 2014 | 30 | 0.150 |
Why?
|
| Checklist | 1 | 2017 | 36 | 0.140 |
Why?
|
| Hypertrophy | 1 | 2017 | 19 | 0.140 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 17 | 0.140 |
Why?
|
| Biliary Tract Diseases | 2 | 1994 | 4 | 0.140 |
Why?
|
| Liver Regeneration | 1 | 2017 | 20 | 0.140 |
Why?
|
| Follow-Up Studies | 7 | 2014 | 1710 | 0.140 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 72 | 0.140 |
Why?
|
| Acute Disease | 4 | 2018 | 189 | 0.140 |
Why?
|
| Portal Vein | 1 | 2017 | 38 | 0.140 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 5 | 0.130 |
Why?
|
| Enterostomy | 1 | 2016 | 5 | 0.130 |
Why?
|
| Gastrectomy | 2 | 2015 | 29 | 0.130 |
Why?
|
| Hypertension, Portal | 1 | 1995 | 1 | 0.130 |
Why?
|
| Ascites | 1 | 1995 | 4 | 0.130 |
Why?
|
| Intensive Care Units | 1 | 2018 | 279 | 0.130 |
Why?
|
| Algorithms | 1 | 2018 | 358 | 0.130 |
Why?
|
| Blood Coagulation Disorders | 1 | 1995 | 14 | 0.130 |
Why?
|
| Hospital Costs | 1 | 1996 | 62 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2014 | 211 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 66 | 0.120 |
Why?
|
| Palliative Care | 1 | 1996 | 104 | 0.120 |
Why?
|
| Cholangiography | 5 | 2015 | 11 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2018 | 621 | 0.120 |
Why?
|
| Appendectomy | 1 | 2014 | 15 | 0.120 |
Why?
|
| Liver Diseases | 1 | 1995 | 31 | 0.120 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 12 | 0.120 |
Why?
|
| Problem-Based Learning | 1 | 2014 | 7 | 0.120 |
Why?
|
| Appendicitis | 1 | 2014 | 17 | 0.120 |
Why?
|
| Congenital Abnormalities | 1 | 2014 | 10 | 0.120 |
Why?
|
| Hernia, Hiatal | 1 | 2014 | 9 | 0.120 |
Why?
|
| Lymphoma | 1 | 2014 | 36 | 0.120 |
Why?
|
| Biliary Fistula | 2 | 2014 | 6 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 104 | 0.120 |
Why?
|
| Models, Educational | 1 | 2014 | 33 | 0.120 |
Why?
|
| Intestine, Small | 2 | 2014 | 27 | 0.120 |
Why?
|
| Abdominal Pain | 2 | 1991 | 8 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 2 | 1995 | 34 | 0.120 |
Why?
|
| Duodenal Neoplasms | 2 | 2013 | 4 | 0.120 |
Why?
|
| Hemobilia | 1 | 2014 | 1 | 0.120 |
Why?
|
| Respiratory Tract Fistula | 1 | 2014 | 1 | 0.120 |
Why?
|
| Mirizzi Syndrome | 1 | 2014 | 1 | 0.120 |
Why?
|
| Cutaneous Fistula | 1 | 2014 | 3 | 0.110 |
Why?
|
| Duodenal Diseases | 1 | 2014 | 2 | 0.110 |
Why?
|
| Ileus | 1 | 2014 | 3 | 0.110 |
Why?
|
| Urinary Fistula | 1 | 2014 | 3 | 0.110 |
Why?
|
| Intestinal Fistula | 1 | 2014 | 4 | 0.110 |
Why?
|
| Vascular Fistula | 1 | 2014 | 3 | 0.110 |
Why?
|
| Credentialing | 1 | 2014 | 7 | 0.110 |
Why?
|
| Prognosis | 7 | 2018 | 749 | 0.110 |
Why?
|
| Elective Surgical Procedures | 1 | 2014 | 38 | 0.110 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2013 | 35 | 0.110 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 179 | 0.100 |
Why?
|
| Biliary Tract Neoplasms | 2 | 1991 | 3 | 0.100 |
Why?
|
| Sepsis | 1 | 2014 | 137 | 0.100 |
Why?
|
| Lithotripsy | 1 | 1992 | 2 | 0.100 |
Why?
|
| Physicians | 1 | 2014 | 108 | 0.100 |
Why?
|
| Young Adult | 1 | 2018 | 1848 | 0.100 |
Why?
|
| Appendiceal Neoplasms | 1 | 1991 | 2 | 0.100 |
Why?
|
| Sarcoma, Kaposi | 1 | 1991 | 3 | 0.100 |
Why?
|
| Opportunistic Infections | 1 | 1990 | 7 | 0.090 |
Why?
|
| Risk Factors | 4 | 2020 | 2240 | 0.090 |
Why?
|
| Logistic Models | 3 | 2016 | 360 | 0.090 |
Why?
|
| Recurrence | 3 | 2014 | 306 | 0.080 |
Why?
|
| Databases, Factual | 3 | 2016 | 324 | 0.080 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2014 | 308 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 1 | 2007 | 34 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1988 | 160 | 0.070 |
Why?
|
| Registries | 1 | 2007 | 171 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 485 | 0.060 |
Why?
|
| Carcinosarcoma | 1 | 2005 | 3 | 0.060 |
Why?
|
| Pancreas | 1 | 2005 | 26 | 0.060 |
Why?
|
| Contraindications | 2 | 1995 | 32 | 0.060 |
Why?
|
| Survival Analysis | 4 | 2015 | 235 | 0.060 |
Why?
|
| Liver Neoplasms | 2 | 1997 | 91 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 1140 | 0.060 |
Why?
|
| Morbidity | 2 | 2014 | 54 | 0.060 |
Why?
|
| Intraoperative Period | 3 | 1997 | 25 | 0.050 |
Why?
|
| Polypropylenes | 1 | 2003 | 2 | 0.050 |
Why?
|
| Polytetrafluoroethylene | 1 | 2003 | 4 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2002 | 43 | 0.050 |
Why?
|
| Duodenum | 2 | 1994 | 6 | 0.050 |
Why?
|
| Hepatectomy | 2 | 2017 | 51 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 670 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 1992 | 277 | 0.040 |
Why?
|
| Anastomosis, Surgical | 2 | 2016 | 26 | 0.040 |
Why?
|
| Time Factors | 3 | 2014 | 1361 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2018 | 7 | 0.040 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2018 | 2 | 0.040 |
Why?
|
| Software Design | 1 | 2017 | 1 | 0.040 |
Why?
|
| Conversion to Open Surgery | 1 | 2017 | 3 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2018 | 14 | 0.040 |
Why?
|
| Gallbladder | 1 | 2017 | 4 | 0.040 |
Why?
|
| Japan | 1 | 2017 | 7 | 0.040 |
Why?
|
| Korea | 1 | 2017 | 9 | 0.040 |
Why?
|
| Taiwan | 1 | 2017 | 7 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 35 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2017 | 23 | 0.040 |
Why?
|
| Conservative Treatment | 1 | 2017 | 16 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2018 | 64 | 0.040 |
Why?
|
| Liver Circulation | 1 | 2017 | 2 | 0.040 |
Why?
|
| Portal Pressure | 1 | 2017 | 2 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 96 | 0.040 |
Why?
|
| Ligation | 1 | 2017 | 33 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2018 | 202 | 0.040 |
Why?
|
| Swine | 1 | 2017 | 62 | 0.040 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 68 | 0.040 |
Why?
|
| Organ Size | 1 | 2017 | 95 | 0.040 |
Why?
|
| Consensus | 1 | 2017 | 83 | 0.040 |
Why?
|
| Random Allocation | 1 | 2017 | 119 | 0.040 |
Why?
|
| Laparotomy | 2 | 1997 | 19 | 0.040 |
Why?
|
| Patient Safety | 1 | 2017 | 51 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2015 | 1815 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 375 | 0.030 |
Why?
|
| Gastrostomy | 1 | 1996 | 6 | 0.030 |
Why?
|
| Jejunostomy | 1 | 1996 | 6 | 0.030 |
Why?
|
| Cost Savings | 1 | 1996 | 29 | 0.030 |
Why?
|
| Prothrombin Time | 1 | 1995 | 2 | 0.030 |
Why?
|
| Whole Blood Coagulation Time | 1 | 1995 | 4 | 0.030 |
Why?
|
| Platelet Count | 1 | 1995 | 15 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 1996 | 122 | 0.030 |
Why?
|
| Hemostasis, Surgical | 1 | 1995 | 11 | 0.030 |
Why?
|
| Intestines | 1 | 2016 | 94 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2017 | 482 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 1995 | 20 | 0.030 |
Why?
|
| Neuroendocrine Tumors | 1 | 1995 | 21 | 0.030 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1995 | 20 | 0.030 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 1996 | 72 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 64 | 0.030 |
Why?
|
| Competitive Behavior | 1 | 2014 | 4 | 0.030 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 1994 | 3 | 0.030 |
Why?
|
| Punctures | 1 | 1994 | 10 | 0.030 |
Why?
|
| Abdominal Injuries | 1 | 1994 | 4 | 0.030 |
Why?
|
| Hemoglobins | 1 | 1995 | 74 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 73 | 0.030 |
Why?
|
| Colonic Diseases | 1 | 2014 | 9 | 0.030 |
Why?
|
| Stomach | 1 | 1994 | 13 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 226 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2014 | 63 | 0.030 |
Why?
|
| Cholestasis | 1 | 1993 | 8 | 0.030 |
Why?
|
| Wound Healing | 1 | 2014 | 146 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2014 | 81 | 0.030 |
Why?
|
| Reoperation | 3 | 2002 | 874 | 0.030 |
Why?
|
| Puerto Rico | 1 | 1993 | 10 | 0.030 |
Why?
|
| Endocrine Gland Neoplasms | 1 | 1992 | 1 | 0.030 |
Why?
|
| Nervous System Neoplasms | 1 | 1992 | 1 | 0.030 |
Why?
|
| Pancreatitis | 2 | 2003 | 19 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 1993 | 37 | 0.030 |
Why?
|
| Data Collection | 1 | 1993 | 91 | 0.030 |
Why?
|
| Colic | 1 | 1992 | 1 | 0.030 |
Why?
|
| Ursodeoxycholic Acid | 1 | 1992 | 5 | 0.030 |
Why?
|
| Incidence | 1 | 1994 | 706 | 0.020 |
Why?
|
| Neurosecretory Systems | 1 | 1991 | 9 | 0.020 |
Why?
|
| Emergencies | 1 | 1990 | 33 | 0.020 |
Why?
|
| Animals | 1 | 2017 | 3386 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 1987 | 10 | 0.020 |
Why?
|
| Bile Duct Neoplasms | 1 | 1986 | 3 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 457 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1988 | 224 | 0.020 |
Why?
|
| Common Bile Duct | 1 | 1986 | 2 | 0.020 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 1986 | 3 | 0.020 |
Why?
|
| Angiography | 1 | 1986 | 27 | 0.020 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2003 | 5 | 0.010 |
Why?
|
| Peritoneum | 1 | 2003 | 15 | 0.010 |
Why?
|
| Medical Records | 1 | 2002 | 30 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2002 | 416 | 0.010 |
Why?
|
| Age Factors | 2 | 1997 | 742 | 0.010 |
Why?
|
| Adolescent | 1 | 1986 | 2062 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1999 | 293 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 1997 | 75 | 0.010 |
Why?
|
| Sex Factors | 1 | 1997 | 442 | 0.010 |
Why?
|
| Peptic Ulcer | 1 | 1994 | 3 | 0.010 |
Why?
|
| Digestive System Neoplasms | 1 | 1993 | 4 | 0.010 |
Why?
|
| Gastroplasty | 1 | 1994 | 23 | 0.010 |
Why?
|
| Contrast Media | 1 | 1994 | 60 | 0.010 |
Why?
|
| Leiomyosarcoma | 1 | 1993 | 21 | 0.010 |
Why?
|
| Gastric Bypass | 1 | 1994 | 67 | 0.010 |
Why?
|
| Radiography | 1 | 1994 | 610 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1991 | 2 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1991 | 15 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1992 | 313 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1991 | 124 | 0.010 |
Why?
|
| Pancreatic Fistula | 1 | 1986 | 2 | 0.000 |
Why?
|
| Gastric Emptying | 1 | 1986 | 12 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1986 | 35 | 0.000 |
Why?
|